Elias Jabbour
MD
Professor, Department of Leukemia
👥Biography 个人简介
Elias Jabbour has defined the role of ponatinib and other TKIs in the treatment of Philadelphia chromosome-positive ALL. He led trials combining ponatinib with reduced-intensity chemotherapy and blinatumomab in Ph+ ALL, achieving high rates of molecular remission. His work has pushed toward chemotherapy-free frontline approaches for Ph+ ALL using TKI plus immunotherapy combinations.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Elias Jabbour 的研究动态
Follow Elias Jabbour's research updates
留下邮箱，当我们发布与 Elias Jabbour（MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment